Acquired CTNNB1 Mutation Drives Immune Checkpoint Inhibitor-Acquired Resistance in a Microsatellite Instability-High Gastroesophageal Adenocarcinoma With Brain Metastases.

Autor: Klempner SJ; Samuel J. Klempner, The Angeles Clinic and Research Institute, and Cedars-Sinai Medical Center, Los Angeles, CA; Alexa B. Schrock and Siraj M. Ali, Foundation Medicine, Cambridge, MA; and Charlotte D. Kubicky and Matthew H. Taylor, Oregon Health & Science University, Portland, OR., Schrock AB; Samuel J. Klempner, The Angeles Clinic and Research Institute, and Cedars-Sinai Medical Center, Los Angeles, CA; Alexa B. Schrock and Siraj M. Ali, Foundation Medicine, Cambridge, MA; and Charlotte D. Kubicky and Matthew H. Taylor, Oregon Health & Science University, Portland, OR., Ali SM; Samuel J. Klempner, The Angeles Clinic and Research Institute, and Cedars-Sinai Medical Center, Los Angeles, CA; Alexa B. Schrock and Siraj M. Ali, Foundation Medicine, Cambridge, MA; and Charlotte D. Kubicky and Matthew H. Taylor, Oregon Health & Science University, Portland, OR., Kubicky CD; Samuel J. Klempner, The Angeles Clinic and Research Institute, and Cedars-Sinai Medical Center, Los Angeles, CA; Alexa B. Schrock and Siraj M. Ali, Foundation Medicine, Cambridge, MA; and Charlotte D. Kubicky and Matthew H. Taylor, Oregon Health & Science University, Portland, OR., Taylor MH; Samuel J. Klempner, The Angeles Clinic and Research Institute, and Cedars-Sinai Medical Center, Los Angeles, CA; Alexa B. Schrock and Siraj M. Ali, Foundation Medicine, Cambridge, MA; and Charlotte D. Kubicky and Matthew H. Taylor, Oregon Health & Science University, Portland, OR.
Jazyk: angličtina
Zdroj: JCO precision oncology [JCO Precis Oncol] 2019 Dec; Vol. 3, pp. 1-6.
DOI: 10.1200/PO.18.00208
Databáze: MEDLINE